Literature DB >> 16304352

Venous thrombosis: the role of genes, environment, and behavior.

Frits R Rosendaal1.   

Abstract

Over the last decade we have witnessed an avalanche of newly identified risk factors for venous thrombosis. This has advanced our knowledge of its etiology, because more determinants have been described and because the underlying concepts have received a new and broader understanding. Venous thrombosis is a common multicausal disease occurring as the result of interacting genetic, environmental and behavioral risk factors. Some of these have been known since medieval times, such as the increased risk of thrombosis during immobilization in pregnancy and after childbirth (although retained milk of the breast-feeding mother was seen as the primary cause for the latter). Pregnancy and puerperium still cause thrombosis, as do exogenous hormones in oral contraceptives and hormonal replacement therapy. Furthermore, the immobilization in the puerperium of the old days translates directly to situations of immobilization in current times, such as prolonged travel in airplanes or excessive electronic gaming. While pedigrees with abundant thrombosis were observed in the early 1900s, the first cause of heritable thrombophilia (antithrombin deficiency) was discovered in 1965, with the subsequent identification of deficiencies of protein C and protein S in the early 1980s. These were uncommon and strong risk factors, whereas the more recently discovered genetic variants are common and weak, and cause disease only in the presence of other factors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16304352     DOI: 10.1182/asheducation-2005.1.1

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  42 in total

Review 1.  Limitations of conventional anticoagulant therapy and the promises of non-heparin based conformational activators of antithrombin.

Authors:  Qudsia Rashid; Poonam Singh; Mohammad Abid; Mohamad Aman Jairajpuri
Journal:  J Thromb Thrombolysis       Date:  2012-08       Impact factor: 2.300

Review 2.  Risk factors for venous and arterial thrombosis.

Authors:  Emanuele Previtali; Paolo Bucciarelli; Serena M Passamonti; Ida Martinelli
Journal:  Blood Transfus       Date:  2010-10-25       Impact factor: 3.443

Review 3.  Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management.

Authors:  Anna K Jönsson; Olav Spigset; Staffan Hägg
Journal:  CNS Drugs       Date:  2012-08-01       Impact factor: 5.749

4.  Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation.

Authors:  Ymir Saemundsson; Signý Vala Sveinsdottir; Henrik Svantesson; Peter J Svensson
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

5.  Prothrombin G20210A mutation is associated with young-onset stroke: the genetics of early-onset stroke study and meta-analysis.

Authors:  Baijia Jiang; Kathleen A Ryan; Ali Hamedani; Yuching Cheng; Mary J Sparks; Deborah Koontz; Christopher J Bean; Margaret Gallagher; W Craig Hooper; Patrick F McArdle; Jeffrey R O'Connell; O Colin Stine; Marcella A Wozniak; Barney J Stern; Braxton D Mitchell; Steven J Kittner; John W Cole
Journal:  Stroke       Date:  2014-03-11       Impact factor: 7.914

6.  Interaction of a genetic risk score with physical activity, physical inactivity, and body mass index in relation to venous thromboembolism risk.

Authors:  Jihye Kim; Peter Kraft; Kaitlin A Hagan; Laura B Harrington; Sara Lindstroem; Christopher Kabrhel
Journal:  Genet Epidemiol       Date:  2018-03-08       Impact factor: 2.135

7.  Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism.

Authors:  Marta Crous-Bou; Immaculata De Vivo; Carlos A Camargo; Raphaëlle Varraso; Francine Grodstein; Majken K Jensen; Peter Kraft; Samuel Z Goldhaber; Sara Lindström; Christopher Kabrhel
Journal:  Thromb Haemost       Date:  2016-06-16       Impact factor: 5.249

Review 8.  Environmental and Genetic Risk Factors Associated with Venous Thromboembolism.

Authors:  Marta Crous-Bou; Laura B Harrington; Christopher Kabrhel
Journal:  Semin Thromb Hemost       Date:  2016-10-20       Impact factor: 4.180

Review 9.  Budd-Chiari syndrome/hepatic venous outflow tract obstruction.

Authors:  Dominique-Charles Valla
Journal:  Hepatol Int       Date:  2017-07-06       Impact factor: 6.047

10.  Risk factors of venous thromboembolism in thai patients.

Authors:  Pantep Angchaisuksiri; Vichai Atichartakarn; Katcharin Aryurachai; Napaporn Archararit; Buppa Rachakom; Kanlayanee Atamasirikul; Arjit Tiraganjana
Journal:  Int J Hematol       Date:  2007-12       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.